The company
Entera Bio Ltd. -
ENTX · Nasdaq
ENTX stood above a rising 150-day average in 19 of the last 52 weekly readings, including each of the last 12 weeks. It is 49.1% above that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).
Statistics
- Rotation
- Leading
- Weeks in an uptrend
- 12 in a row
- Industry in uptrend
- 16% -15 in 4 wk
- Insider buys, 12 months
- $262K
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 0
- Institutions holding
- 24 (+0)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 19 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Geno J. GermanoDirector | bought | 20,000at $1.30 | 9 Mar 2026filed 11 Mar 2026 |
| Sean EllisDirector | bought | 10,000at $1.23 | 5 Mar 2026filed 9 Mar 2026 |
| Steven D. RubinDirector | bought | 5,000at $1.49 | 12 Feb 2026filed 17 Feb 2026 |
| Geno J. GermanoDirector | bought | 20,000at $1.49 | 10 Feb 2026filed 11 Feb 2026 |
| Haya TaitelDirector | bought | 7,500at $1.48 | 10 Feb 2026filed 11 Feb 2026 |
| Sean EllisDirector | bought | 18,000at $1.24 | 9 Feb 2026filed 11 Feb 2026 |
| Steven D. RubinDirector | bought | 10,000at $1.20 | 9 Feb 2026filed 11 Feb 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| Knoll Capital Management, LLCunchanged · filed 14 Aug 2026 | 5,881,879$10.4M | 00.0% |
| BVF INCnew · filed 14 Aug 2026 | 2,425,000$4.3M | +2,425,000 |
| Siren, L.L.C.new · filed 13 Aug 2026 | 736,457$1.3M | +736,457 |
| RENAISSANCE TECHNOLOGIES LLCreduced · filed 13 Aug 2026 | 368,847$653K | -104,595−22.1% |
| Parkman Healthcare Partners LLCreduced · filed 14 Aug 2026 | 274,497$486K | -14,173−4.9% |
| PNC Financial Services Group, Inc.added · filed 7 Aug 2026 | 273,031$483K | +263,031+2630.3% |
| Seven Fleet Capital Management LPreduced · filed 17 Aug 2026 | 191,354$339K | -14,188−6.9% |
| HighTower Advisors, LLCadded · filed 5 Aug 2026 | 74,573$133K | +37,743+102.5% |
| Schonfeld Strategic Advisors LLCadded · filed 14 Aug 2026 | 58,871$104K | +3,648+6.6% |
| TWO SIGMA SECURITIES, LLCnew · filed 14 Aug 2026 | 48,593$86K | +48,593 |
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.